Therapeutic App for Tinnitus Improves Tinnitus-Related Distress
Medically reviewed by Drugs.com
via HealthDayFRIDAY, May 8, 2026 -- Use of a therapeutic app for tinnitus that provides educational counseling and cognitive behavioral therapy (CBT) results in substantial improvement in tinnitus-related distress, according to a study published online May 7 in JAMA Otolaryngology–Head & Neck Surgery.
Koichiro Wasano, M.D., Ph.D., from the Tokai University School of Medicine in Japan, and colleagues developed a prototype digital therapeutic mobile app that provides educational counseling and CBT elements for treating chronic tinnitus symptoms. Safety and efficacy were assessed for 16 weeks in a double-blind, sham-controlled trial involving 60 patients diagnosed with mild-to-severe chronic tinnitus. Participants used the therapeutic app or a sham control app that lacked the therapeutic functions (30 in each group). The therapeutic functions of the app were blocked during the eight-week follow-up.
At week 16, the researchers found a significantly greater improvement in Tinnitus Handicap Inventory (THI) scores in the therapeutic group versus the sham group (between-group difference in change in THI, −20.4). The therapeutic effect was maintained to week 24 (mean between-group difference, −18.3). In one patient in the sham control app group, tinnitus worsened. There were no serious adverse events or device malfunctions with potential for health hazards.
"The tinnitus treatment app may be an effective intervention for individuals with chronic tinnitus, offering a standardized approach to treatment," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-09 09:32
Read more
- Merck and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for Certain Patients With Advanced Renal Cell Carcinoma (RCC)
- CMS Extends Medicare's Short-Term Bridge Program for GLP-1 Obesity Drug Coverage
- Uterine Fibroid Prevalence May Be Lower Than Thought in Latina Women
- Children Most in Need of Dental Care Less Likely to Participate in School-Based Prevention Programs
- Most Calcitonin Gene-Related Peptide Targeted Therapies Effective for Migraine Prophylaxis
- FDA Grants Accelerated Approval for Otarmeni (lunsotogene parvec-cwha) Gene Therapy for Genetic Hearing Loss
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions